Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies-Reference-Cited by-同舟云学术

Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies

Published:2016-02-15 Issue:35 Volume:35 Page:4663-4674
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Zhou J,Luo J,Wu K,Yun E-j,Kapur P,Pong R-C,Du Y,Wang B,Authement C,Hernandez E,Yang J,Xiao G,Cha T-L,Wu H-C,Wu D,Margulis V,Lotan Y,Brugarolas J,He D,Hsieh J-T

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc20164.pdf

Reference50 articles.

1. Cohen HT, McGovern FJ . Renal-cell carcinoma. N Engl J Med 2005; 353: 2477–2490.

2. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013; 499: 43–49.

3. Dalgliesh GL, Furge K, Greenman C, Chen L, Bignell G, Butler A et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 2010; 463: 360–363.

4. Kucejova B, Pena-Llopis S, Yamasaki T, Sivanand S, Tran TA, Alexander S et al. Interplay between pVHL and mTORC1 pathways in clear-cell renal cell carcinoma. Mol Cancer Res 2011; 9: 1255–1265.

5. Pena-Llopis S, Vega-Rubin-de-Celis S, Liao A, Leng N, Pavia-Jimenez A, Wang S et al. BAP1 loss defines a new class of renal cell carcinoma. Nat Genet 2012; 44: 751–759.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA Methylation as Drug Sensitivity Marker in RCC: A Systematic Review;Epigenomes;2024-07-15

2. An update on the tumor-suppressive functions of the RasGAP protein DAB2IP with focus on therapeutic implications;Cell Death & Differentiation;2024-06-20

3. DAB2IP inhibits glucose uptake by modulating HIF-1α ubiquitination under hypoxia in breast cancer;Oncogenesis;2024-06-11

4. Molecular characteristics and prognostic significances of lysosomal-dependent cell death in kidney renal clear cell carcinoma;Aging;2024-03-07

5. DAB2IP inhibits glucose uptake by modulating HIF-1a ubiquitination under hypoxia in breast cancer;2024-01-18